4//SEC Filing
SHERMAN STEVEN 4
Accession 0001549084-22-000073
CIK 0001549084other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 3:17 PM ET
Size
9.2 KB
Accession
0001549084-22-000073
Insider Transaction Report
Form 4
SHERMAN STEVEN
Director
Transactions
- Sale
Common Stock
2022-11-21$1.26/sh−5,787$7,312→ 708,042 total - Exercise/Conversion
Common Stock
2022-11-21+15,599→ 713,829 total - Exercise/Conversion
Restricted Stock Units
2022-11-21−15,599→ 31,199 total→ Common Stock (15,599 underlying)
Footnotes (4)
- [F1]Represents shares sold by the Reporting Person on November 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the tenth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022
- [F2]The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.26 to $1.27, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.
- [F3]The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
- [F4]The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The tenth installment of RSUs vested on November 21, 2022 and were delivered to the Reporting Person upon settlement.
Documents
Issuer
EKSO BIONICS HOLDINGS, INC.
CIK 0001549084
Entity typeother
Related Parties
1- filerCIK 0001201619
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 3:17 PM ET
- Size
- 9.2 KB